Endocrinologia Pediátrica: Diretrizes Médicas (Pediatric Endocrinology: Guidelines)
■ Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children
Rocío Galindo-Zavala, Rosa Bou-Torrent, Berta Magallares-López et al
Pediatr Rheumatol Online J. 2020; 18: 20
https://ped-rheum.biomedcentral.com/articles/10.1186/s12969-020-0411-9
■ EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
Sabina Baumgartner-Parzer, Martina Witsch-Baumgartner, Wolfgang Hoeppner
Eur J Hum Genet. 2020 Oct; 28(10): 1341–1367
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609334/
■ Evolving pituitary hormone deficits in primarily isolated GHD: a review and expert´s consensus
Gerhard Binder, Dirk Schnabel, Thomas Reinehr et al
Mol Cell Pediatr. 2020 Dec; 7: 16
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606365/
■ Genetic causes of hypopituitarism
Katherine Parkin, Ritika Kapoor, Ravindra Bhat, Anne Greenough
Arch Med Sci. 2020; 16(1): 27–33.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963153/
■ Newborn feeding recommendations and practices increase the risk of development of overweight and obesity
Brittany Watchmaker, Bridget Boyd, Lara R. Dugas
BMC Pediatr. 2020; 20: 104
https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-020-1982-9
■ Monitoring of pediatric type 1 diabetes
Brynn E. Marks, Joseph I. Wolfsdorf
Front Endocrinol (Lausanne) 2020; 11: 128
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089921/
■ Diagnosis and treatment of growth hormone deficiency: a position statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology
J H Kim, H W Chae, S O Chin et al
Endocrinol Metab (Seoul) 2020, vol 35 (2): 272-27
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386113/
■ Tratamiento con hormona de crecimiento en el síndrome de Noonan: revisión de la bibliografia y recomendaciones de tratamiento
A Carcavilla, L Suárez-Ortega, M Ramón-Krauel et al
Rev Esp Endocrinol Pediatr 2020, vol 11 (1): 23-39
https://www.endocrinologiapediatrica.org/modules.php?name=articulos&idarticulo=584&idlangart=ES
■ Diagnosis, genetics, and therapy of short stature in children: A Growth Hormone Research Society International Perspective
Paulo F. Collett-Solberg, Geoffrey Ambler, Philippe F. Backeljauw et al
Horm Res Paediatr. 2019 Dec; 92(1): 1–14
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979443/
■ Towards a rational and efficient diagnostic approach in children referred for tall stature and/or accelerated growth to the general paediatrician
P Lauffer, G A Kamp, L A Menke et al
On behalf of the Dutch Working Group on Triage and Diagnosis of Growthh Disorders in Children
Horm Res Paediatr 2019, vol 91: 293-310
https://www.karger.com/Article/FullText/500810
■ Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease
J Drube, M Wan, M Bonthuis et al
Eur Thyroid J 2019, vol 8: 227-245
On behalf of the European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups
Nature Reviews Nephrology 2019, vol 15: 577-589
https://www.nature.com/articles/s41581-019-0161-4
■ Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings
Bradley S Miller, Sandra P Spencer, Mitchell E Geffner et al
J Investig Med. 2020 Jan; 68(1): 16–25.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996103/
■ Clinical practice guideline for the diagnosis and treatment of pediatric obesity: recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology Hepatology and Nutrition
Dae Yong Yi, Soon Chul Kim, Ji Hyuk Lee et al
Pediatr Gastroenterol Hepatol Nutr. 2019 Jan; 22(1): 1–27
https://www.e-cep.org/upload/pdf/kjp-2018-07360.pdf
■ Cardiovascular implications in idiopathic and syndromic obesity in childhood: an update
Maurizio Delvecchio, Carmela Pastore, Federica Valente, Paola Giordano
Front Endocrinol (Lausanne) 2020; 11: 330
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296059/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: Fevereiro 2021